Figure 2.
Typical expression map of SELDI-TOF-MS analysis of sera from different stages of TNBC and NTNBC. (A)Typical expression of the 7785 Da peak (left panel, arrow) and gel views (right panel, arrow) at different stages of TNBC (TNBC-I: patient with stage I TNBC; TNBC-II: patient with stage II TNBC; TNBC-III: patient with stage III TNBC; TNBC-IV: patient with stage IV TNBC). (B)The 7785 Da protein peak progressively increased with clinical stage in TNBC(p< 0.0001). (C) Typical expression of the 7785 Da protein (left panel, arrow) and gel views (right panel, arrow) at different stages of NTNBC (NTNBC-I: patient with stage I NTNBC; NTNBC-II: patient with stage II NTNBC; NTNBC-III: patient with stage III NTNBC; NTNBC-IV: patient with stage IV NTNBC). (D) The 7785 Da peak displayed no significant changes with increasing clinical stage in NTNBC(p = 0.052).** p ≤ 0.01,****p ≤ 0.0001.